The global osteoporosis drugs market is valued at US$ 12.5 Bn at present, and is expected to progress at a modest CAGR of 3.8% from 2021 to 2031, to account for US$ 18 Bn by 2031.
The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.
Get Going With Sample Of Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.com/samples/2983
However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.
In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region.
According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.
In Europe, increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market.
According to International Osteoporosis Foundation, approximately 27.5 million people in Europe suffered from osteoporosis in 2010, and the number is expected to reach 33.9 Mn by 2030.
However, the growth of osteoporosis market in Asia Pacific is much due to rising geriatric population and changing lifestyles in the region. Osteoporotic patients have a higher risk of hip fractures, owing to a major cause of morbidity and mortality.
According to the International Osteoporosis Foundation, by 2050, approximately 1/2 of the world’s osteoporosis hip fractures would occur in women in Asia.
Browse the full Global Market Study on Osteoporosis Drugs 2021-2031 report at http://www.persistencemarketresearch.com/market-research/osteoporosis-drugs-market.asp
Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Merck & Co. Inc., Novartis AG, Amgen, Inc., Actavis plc, Teva Pharmaceuticals Industries Ltd., and Pfizer, Inc. are some of the major players of osteoporosis drugs market.
How About Re-Inventing The Methodical Wheel In The Osteoporosis Drugs Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/2983
Market Segmentation:
By Drug Type
- Bisphosphonates
- Parathyroid Hormone Therapy Drugs
- Calcitonin
- Selective Estrogen Receptors Modulators (SERMs)
- RANK Ligand Inhibitors
By Geography
- North America
- The U.S.
- Europe
- Germany
- France
- The U.K.
- Asia
- China
- Japan
- India
- Rest of the World (RoW)
Keeping A Tab On Key Players In The Osteoporosis Drugs Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Osteoporosis Drugs Market Report! https://www.persistencemarketresearch.com/checkout/2983
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Persistence Market Research stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, Persistence Market Research’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Addie Thomas
305 Broadway
7th Floor
New York City, NY 10007
US
USA – Canada Toll Free: 800-961-0353